Upgrade to SI Premium - Free Trial

Morgan Stanley on ProLogis (PLD): 'We believe the key to the guidance cut is the drop in the company's net absorption guidance'

April 17, 2024 10:53 AM
Morgan Stanley analyst Ronald Kamdem reiterated an Overweight rating and $141.00 price target on ProLogis (NYSE: PLD)The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles